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Abstract Presently, 2 to 4 days elapse between sampling at
infection suspicion and result of microbial diagnostics. This
delay for the identification of pathogens causes quite often a
late and/or inappropriate initiation of therapy for patients
suffering from infections. Bad outcome and high hospitali-
zation costs are the consequences of these currently existing
limited pathogen identification possibilities. For this reason,
we aimed to apply the innovative method multi-capillary
column–ion mobility spectrometry (MCC-IMS) for a fast
identification of human pathogenic bacteria by determination
of their characteristic volatile metabolomes. We determined
volatile organic compound (VOC) patterns in headspace of 15
human pathogenic bacteria, which were grown for 24 h on
Columbia blood agar plates. Besides MCC-IMS determina-
tion, we also used thermal desorption–gas chromatography–
mass spectrometry measurements to confirm and evaluate
obtained MCC-IMS data and if possible to assign volatile
compounds to unknown MCC-IMS signals. Up to 21 specific
signals have been determined by MCC-IMS for Proteus mir-
abilis possessing the most VOCs of all investigated strains. Of
particular importance is the result that all investigated strains
showed different VOC patterns by MCC-IMS using positive
and negative ion mode for every single strain. Thus, the
discrimination of investigated bacteria is possible by detection
of their volatile organic compounds in the chosen experimen-
tal setup with the fast and cost-effective methodMCC-IMS. In
a hospital routine, this method could enable the identification
of pathogens already after 24 h with the consequence that a
specific therapy could be initiated significantly earlier.
Keywords Pathogen identification . Volatile metabolome .
Multi-capillary column (MCC) . Ion mobility spectrometry
(IMS) . Volatile organic compound (VOC)
Introduction
The treatment of suspected bacterial infections like pneu-
monia or sepsis represents a difficult dilemma for the clini-
cian. Due to a lack of knowledge about the identity of
infecting pathogen at the point of infection suspicion, initial
treatment mostly starts with broad-spectrum antibiotic ther-
apy followed by narrow-spectrum therapy according to
results of microbiological diagnostic. The argument for this
strategy is that several studies showed that immediate initi-
ation of an appropriate antibiotic therapy was associated
with reduced mortality, reduced length of intensive care unit
(ICU) stay and reduced costs (e.g., Kollef 2000; Alvarez-
Lerma 1996; Rello et al. 1997; Kumar et al. 2009). Thus,
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this de-escalating strategy seems to be the preferred ap-
proach rather than starting narrow-spectrum therapy and
then broadening the spectrum if necessary once culture data
are available. In addition, an optimal therapy and thus, the
reduction of inappropriate and over treatment may minimize
the risk of resistance development seriously (Arias and
Murray 2009; Burgess 2009; Chastre 2008).
A fast and efficient determination of pathogens is there-
fore urgently needed to immediately initiate an appropriate
therapy with infection suspicion. Currently, the identity of
microorganisms is classically determined using bacterial
culture characterization combined with biochemical and
susceptibility tests, which takes 2 to 4 days. Consequently,
the results are not available early enough to guide antibiotic
management in an early stage of the treatment.
Much work has been done in the last decade to
overcome the problem of the missing fast and reliable
pathogen identification. Different approaches were used
for that purpose like proteome based identification by
matrix-assisted laser desorption–time-of-flight mass spec-
trometry (Seng et al. 2009; Barbuddhe et al. 2008) and
molecular biological based identification by DNA micro-
array and PCR (Yoo et al. 2009; Palka-Santini et al.
2009). Besides, first attempts have been made to omit
the time intensive cultivation, which is also important for
non-cultivatable bacteria (Fenollar and Raoult 2007;
Bahrani-Mougeot et al. 2007). But molecular biological
methods are with, e.g., EUR 300/test (Lehmann et al.
2010), relatively cost-intensive though.
Next to the proteomic and genomic based pathogen dif-
ferentiation is a differentiation by metabolic profiling, as
metabolism of microorganisms is associated with biodegra-
dation of substrates to products. Some of these products are
volatile organic compounds (VOCs) and can therefore be
detected in headspace of microbial cultures.
First scientific evidence for microbial VOCs have been
presented in 1921 and 1976 already (Zoller and Clark 1921;
Stotzky and Schenck 1976) and the role of VOCs for medical
application gains more andmore interest in nowadays (Phillips
et al. 2008; Westhoff et al. 2007; Chaim et al. 2003). Since
technology has developed in recent years, more than 120
different VOCs have been detected from Actinomycetes and
80 different VOCs from Streptomyces for example (Schöller et
al. 2002; Dickschat et al. 2005). An overview of volatile
microbial compounds and their current detection methods has
been given in recent publications (Schulz and Dickschat 2007;
Kai et al. 2009; Korpi et al. 2009).
A comparatively new approach, which is aimed in this
study, is the detection of microbial volatiles by multi-
capillary column (MCC)–ion mobility spectrometry (IMS).
IMS is well-known for applications like the detection of
chemical warfare agents, explosives, and drugs (Eiceman
and Karpas 2005; Baumbach and Eiceman 1999; Roehl
1991). New applications in recent years are microbial VOC
detections in headspace of microbial cultures (Ruzsanyi et al.
2002; Snyder et al. 1991; Smith et al. 1997; Perl et al. 2011) or
even over clinical samples directly (Chaim et al. 2003). Also
differential mobility spectrometry, a closely related technology,
has been used for that purpose already (Shnayderman et al.
2005). IMS provides a high sensitivity (detection limits down
to ng/L-range to pg/L-range, ppbv-range, and pptv-range) com-
bined with high-speed data acquisition and relatively low
technical expenditure. By coupling the IMS with a MCC for
pre-separation, even the analysis of complex and humid gas
samples is possible. The new aspect in this investigation is the
application of MCC-IMS for a rapid bacterial discrimination
by metabolic profiling. It might be of great importance for
several infections and more promising, for the detection of
pathogens in breath directly.
The present study describes the use of MCC-IMS as an
innovative method to rapidly determine pathogen identities
by their emitted VOC patterns. The aim was to prove the
principle of differentiation of human pathologic bacteria by
metabolic profiling with MCC-IMS. Therefore, 15 clinically
relevant human pathogens were grown on Columbia sheep
blood agar, and headspace of these cultures were analyzed
by MCC-IMS. The results have been validated by help of




The bacteria Acinetobacter baumannii (DSM 24110), Cit-
robacter freundii (DSM 24120), Enterobacter cloacae
(DSM 30054), Escherichia coli (DSM 1103), Hafnia alvei
(DSM 24119), Klebsiella oxytoca (DSM 24121), Klebsiella
pneumoniae (DSM 2026), Proteus mirabilis (DSM 4479),
Pseudomonas aeruginosa (DSM 46358), Serratia marces-
cens (DSM 50904), Staphylococcus aureus (DSM 13661),
Staphylococcus epidermidis (DSM 18857), Staphylococcus
haemolyticus (DSM 24111), Streptococcus agalactiae
(DSM 2134), and Streptococcus pneumoniae (DSM
11967) were cultivated on Columbia sheep blood agar
(Ref. 43041; BioMérieux, Nürtingen, Germany) for 24 h at
37 °C prior to measurement. Cultures have been stored short
term at 4 °C or long term at −80 °C in brain hearth infusion
broth (CM1135, OXOID, Wesel, Germany) supplemented
with 25% glycerol.
Chemicals and reagents
For MCC-IMS reference measurements, ethanol (CAS 64-17-
5), indole (CAS 120-72-9), phenethyl alcohol (CAS 60-12-8),
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2-(methylthio)-ethanol (CAS 5271-38-5), 3-methylbutanal
(CAS 590-86-3), 3-methyl-1-butanol (CAS 123-51-3),
dimethyldisulfide (CAS 624-92-0), 2,3-heptanedione
(CAS 96-04-8), 2,5-dimethylpyrazine (CAS 123-32-0),
phenol (CAS 108-95-2), dimethyl trisulfide (CAS 3658-
80-8), 2-octanone (CAS 111-13-7), 2-acetylthiazole (CAS
24295-03-2), 2-nonanone (CAS 821-55-6), 2-decanone
(CAS 693-54-9), N-(phenylmethylene)-1-propanamine
(CAS 6852-55-7), 2-undecanone (CAS 112-12-9), S-methyl
thiobenzoate (CAS 5925-68-8), benzonitrile (CAS 100-47-0),
and 2,3,5-trimethylpyrazine (CAS 1466-55-1) in HPLC grade
have been used.
Sampling of bacterial volatiles
In order to detect bacterial VOCs a thermal controlled
(37 °C) measurement chamber consistent of stainless
steel, a gas inlet and a gas outlet has been constructed
(Leibniz-Institute for Analytical Sciences—ISAS—e.V.,
Dortmund, Germany). Synthetic air (scientific quality,
AIR LIQUIDE Deutschland, Düsseldorf) was supplied
with 100 mL/min via gas inlet. The gas outlet was either
attached to the MCC-IMS measurement system or to an
adsorption tube (packed with 200 mg Tenax™ GR,
GERSTEL, Mühlheim, Germany) for GC/MS measure-
ment by PTFE tubing (Bohlender, Grünsfeld, Germany).
For MCC-IMS analysis, 10 mL, and for GC/MS analysis,
2 L for sample volume have been used, respectively.
Volatile compounds have been detected of the empty
measurement chamber and of headspace of Columbia sheep
blood agar plates in the measurement chamber to determine
the volatile background. After these blank measurements,
media with bacterial colonies have been measured after 24 h
of cultivation at 37 °C. Headspace of a bacterial culture was
continuously rinsed with a synthetic air flow of 100 mL/min.
Samples were drawn after 5 and 25 min for MCC-IMS anal-
yses, and after 60 min for GC/MS analyses. Each measure-
ment was performed three times.
Sampling of reference substances
A small aliquot of each substance has been filled into a 1 mL
reaction vial (CS-Chromatography Service, Langerwehe)
with a screw cap including a gas-permeable membrane to
reach a concentration of approximately 1–10 ppb of every
reference compound. Afterwards, every reaction vial has been
placed in a 250 mL Schott flask with swivelling screw fitting
(BOHLENDER, Grünsfeld, Germany). Prior to sampling, the
Schott flask containing the reference compound has been
incubated for at least 1 h at room temperature under a constant
flowwith synthetic air of 100mL/min. For eachmeasurement,
the gas outlet of the Schott flask was attached to MCC-IMS
measurement system by PTFE tubing (Bohlender, Grünsfeld,
Germany).
Multi-capillary column–ion mobility spectrometer
Bacterial volatiles were rinsed from the measurement cham-
ber through the 10 mL sample loop at a flow of 100 mL/min
for 5 min, and 10 mL of the sample was afterwards loaded
with a carrier gas flow of 150 mL/min via a six-port-valve
onto a rapidly pre-separating OV-5 multi-capillary column
(20 cm long, consisting of approx. 1,000 parallel glass
capillaries, 3 mm total diameter, 43 μm inner diameter of
a single capillary; MULTICHROM, Novosibirsk, Russia).
The multi-capillary column was operated at a constant tem-
perature of 40 °C and at a flow rate of 150 mL/min using
synthetic air as a carrier gas (scientific quality, AIR
LIQUIDE Deutschland, Düsseldorf). After chromatographic
separation of bacterial volatiles, eluted gas-phase analytes
were ionized by a radioactive ionization source (63Ni,
550 MBq) through charge transfer from prior ionized reactant
ions and analyzed with a coupled IMS instrument according to
Vautz and Baumbach (2008; Leibniz-Institute for Analytical
Sciences—ISAS—e.V., Dortmund, Germany) with the fol-
lowing parameters: synthetic air as drift gas, at a flow rate of
100 mL/min, in an electrical field of 330 V/cm, drift tube
(length 12 cm, 15 mm diameter), shutter grid opening time of
300 μs, spectra length/sample interval of 100 ms, and
spectra resolution of 50 kHz. Under the influence of a
positive or negative external electrical field either pro-
tonated or negatively charged analyte ions moved towards a
detector (Faraday-plate), respectively. During their drift to the
detector, ions are being separated through collision with drift
gas molecules moving in the opposite direction (100mL/min).
Thus, a constant resulting drift velocity is the consequence
depending on size and shape of analyte ions. Ion drift times
are measured and ion velocities are calculated for a known
drift distance in the following. The so-called ion mobility was
then calculated by normalizing drift velocity to the electric
field. Finally, reduced ion mobility which is characteristic for
an ion and independent on the experimental conditions has
been determined by further normalization to temperature and
pressure (Vautz et al. 2009).
The specific reduced ion mobility and retention time
related to a particular signal in the MCC-IMS data enables
the identification of the corresponding molecule by compar-
ison with a database. For unknown signals which are not
available in the MCC-IMS database, identification is possi-
ble only by accompanying sampling on adsorption materials
for analysis by GC/MS resulting in a proposed analyte,
followed by a measurement of the reference analyte by
MCC-IMS for validation. Moreover, the MCC-IMS signal
intensity is a measure for the concentration of VOCs in gas
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samples and can be used for quantification under specific
conditions by help of an external calibration.
Thermal desorption–gas chromatography–mass
spectrometry
Volatile organic compounds were thermally desorbed
from Tenax material (Tenax™ GR, GERSTEL, Mühlheim,
Germany) using the following temperature program: initial
temperature of 25 °C was increased by 30 °C/s to 250 °C,
2.5 min isothermal at 250 °C, splitless for 2 min at a flow rate
of 60 mL/min, using helium as carrier gas. Volatile analytes
were then transferred at 300 °C to an integrated cooled injec-
tion system (CIS; GERSTEL, Mühlheim, Germany), fo-
cused at −120 °C, released onto a HP-5MS capillary
column (60 m×0.25 mm×0.25 μm film thickness; Agi-
lent Technologies, Santa Clara, CA, USA) after the CIS
was heated to 250 °C (by 12 °C/min) and temperature was
held for 10 min. The GC/MS analysis was performed on an
Agilent Technologies 7890A GC system connected with an
Agilent Technologies 5975C inert XL mass selective detector
(MSD; Agilent Technologies, Santa Clara, CA, USA) at an
initial oven temperature of 35 °C which was kept for 2 min,
increased by 7 °C/min to 250 °C and held for 7 min. The
separation was performed with helium as carrier gas at a
constant flow rate of 1.0 mL/min. Electron ionization mode
was set at 70 eV and the mass rage of m/z 33–450 was
detected.
MCC-IMS data analysis
Detected MCC-IMS signals have been evaluated using
BB_IMSAnalyse 1.0 (Leibniz-Institute for Analytical Sci-
ences—ISAS—e.V., Dortmund, Germany). Data are repre-
sented as a matrix of signal intensities where the x-axis
indicates the inverse ion mobility in volt second per square
centimetre (Vs/cm2) and the y-axis indicates the retention
time in seconds in a topographic plot (Figs. 1 and 4). In
order to normalize all MCC retention times for a better
comparison of data, the previously described MCC retention
time of 118.3 s for benzothiazole (Perl et al. 2010), a
permanent contaminant of synthetic air, has been used.
Minor variations in drift and retention time have been cor-
rected by alignment according to Vautz et al. (2009) and Perl
et al. (2010). Identification of MCC-IMS signals was per-
formed by comparison of properties of detected signals with
information of a database of reference compounds (Leibniz-
Institute for Analytical Sciences—ISAS—e.V., Dortmund,
Germany) or by own reference measurements. Unidentified
detected compounds were named after their position in the
2D topographic plot as p_1000 × inverse ion mobility_re-
tention time (e.g., p_642_1; 0.642 Vs/cm2, 1 s).
Thermal desorption–gas chromatography–mass
spectrometry data analysis
GC/MS data have been evaluated by MSD ChemStation
Data Analysis Application (Agilent Technologies, Santa
Clara, CA, USA) and compound mass spectra were identi-
fied by AMDIS/NIST (Automated Mass Spectral Deconvo-
lution and Identification System; version 2.62, 2005; NIST
version 2.0, 2005).
Results
Determination of bacterial volatiles by MCC-IMS
All bacterial strains investigated in this study release volatile
organic compounds detectable with MCC-IMS (Table 1).
By comparison of bacterial VOC patterns with volatiles of
Columbia sheep blood agar, several blood agar related com-
pounds have been determined in the positive and negative
ion mode by MCC-IMS. These blood agar related com-
pounds were neglected when comparing bacterial strains.
The location of single signals in a 2D topographic plot is
shown in Fig. 1. All compounds determined by this method
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Fig. 1 Summarized MCC-IMS topographic plot of bacterial volatiles,
which can be used for bacterial discrimination. Fifteen (1–15) com-
pounds have been determined in positive (a) and 16 (17–32) com-
pounds have been determined in negative ion detection mode (b). All
depicted compounds are listed in Table 1
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termed by their names or by numbers from 1 to 32 according
to Table 1, which is summarizing MCC-IMS results. In
addition, the occurrence of the most important VOCs for
specification and discrimination in headspace of investigated
bacteria is illustrated as region comparison analysis in Fig. 2.
Fifteen significant bacterial volatiles were detected in
positive ion mode (1–15) and further 16 significant signals
were detected in negative ion mode (17–32) in headspace of


















































































































































































































































































































































Fig. 2 Region comparison image of MCC-IMS analyses of bacterial
volatiles. Only monomeric MCC-IMS signals are shown. Red boxes
indicate the presence of a VOC, which can be used for bacterial
discrimination. Signals from 1 to 14 have been determined in positive
ion mode, whereas signals from 17 to 29 have been determined in
negative ion mode. An example of headspace VOCs of sheep blood
agar and one example of headspace of every bacterial strain is dis-
played. All strains have been cultivated for 24 h. Signal intensities are
illustrated by different colours (white 0 zero, blue 0 low, red 0 medi-
um, yellow 0 high). The following signals have been used for further
analyses: 1 ethanol, 2 indole, 3 phenethyl alcohol, 4 p_649_194, 5
p_675_194, 6 p_679_429, 7 p_700_423, 8 p_711_3, 9 p_749_26, 10
p_749_37, 11 p_771_54, 13 p_793_19, 14 p_794_12, 17 phenethyl
alcohol, 18 p_493_17, 19 p_543_12, 20 p_563_24, 21 p_572_8, 22 2-
(methylthio)-ethanol, 25 indole, 26 p_629_10, 27 p_654_20, 28
p_681_36 and 29 p_688_22
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compounds can be expected to enable bacterial differentia-
tion (Table 1). Based on that fact, a specific VOC pattern has
been determined for every investigated strain. This includes
furthermore that for S. pneumoniae only one emitted VOC
has been detected, whereas for P. mirabilis on the other hand
21 generated signals were determined. VOC pattern com-
parison revealed that all 15 strains are distinguishable un-
equivocally by MCC-IMS even if the chemical identity of
most VOCs has not unambiguously been identified so far. A
recently published study by Jünger et al. (2010) suggested
an efficient identification strategy of unknown MCC-IMS
signals by additionally performed thermal desorption GC/
MS. This approach was the secondary aim of this study,
which leads to the assignment of ethanol (1), indole (2, 25,
31), phenethyl alcohol (3, 17) and 2-(methylthio)-ethanol
(22), variably present over several investigated bacteria. The
respective reference compounds ethanol, indole, phenethyl
alcohol and 2-(methylthio)-ethanol were measured separately
by MCC-IMS and confirmed our assumptions. It has to be
emphasized that indole, phenethyl alcohol and 2-(methylthio)-
ethanol are detectable in positive as well as in negative ion
mode as their proton bound analyte molecules and anions
have been formed in the corresponding mode. Due to assign
more VOCs, further reference measurements have been per-
formed (Table 2, 33–49), but even if these compounds could
definitely be assigned to MCC-IMS signals after the analysis,
determination of these compounds in headspace of bacteria
gave unsatisfying result. Either the separation from other
occurring compounds over investigated strains was not satis-
factory or signals could not be detected in the expected area
due to amounts present probably below the detection limit,
since 10 mL sample volume has been used for MCC-IMS
analysis only. Different amounts of ammonia (33, reference
data, e.g., Vautz et al. (2010)), also eluting in an area of high
background signal density could be determined over all in-
vestigated strains using positive ion mode (Fig. 3, Table 2).
Consequently, this compound did not provide additional in-
formation that can be used for pathogen differentiation
purpose.
Table 2 By MCC-IMS detectable VOCs using positive ion mode
which do not possess pathogen differentiation potential by this method
due to low amounts in 10 mL headspace or high signal intensity around
respective signals
No. No. GC/MS Rt GC (min) Rt MCC (s) (+) 1/K0 monomer (+) 1/K0 dimer Compound
33 >3.00 3.0 0.451 – Ammonia
34 1* 7.01 3.9 0.599 – 3-Methylbutanal
35 2* 8.48 15.0 0.614 0.742 3-Methyl-1-butanol
36 3* 8.77 6.3 0.488 0.559 Dimethyldisulfide
37 7* 10.95 10.0 0.671 – 2,3-Heptanedione
38 8* 11.57 8.8 0.515 0.583 2-(Methylthio)-ethanol
39 9* 12.80 14.9 0.552 – 2,5-Dimethylpyrazine
40 10* 14.41 22.8 0.529 – Phenol
41 11* 14.47 19.1 0.637 – Dimethyl trisulfide
42 12* 14.74 18.6 0.594 0.730 Benzonitrile
43 13* 14.75 23.6 0.652 0.855 2-Octanone
44 14* 15.09 23.7 0.573 0.792 2,3,5-Trimethylpyranzine
45 16* 15.55 26.0 0.556 0.726 2-Acetylthiazole
46 21* 17.10 51.6 0.686 0.909 2-Nonanone
47 27* 19.31 119.4 0.722 0.968 2-Decanone
48 28* 19.89 121.4 0.621 0.746 N-(Phenylmethylene)-1-propanamine
49 33* 21.42 276.3 0.755 1.017 2-Undecanone
50 35* 21.75 210.0 0.610 0.815 S-Methyl thiobenzoate
Fig. 3 MCC-IMS topographic plot of volatiles which have been
detected in bacterial headspace but have not been chosen for discrim-
ination of bacteria. Because either concentration of VOCs was too low
in 10 mL headspace samples or high density of background signals of
Columbia sheep blood agar, headspace prevents an unambiguous dif-
ferentiation. For compound name, see Table 2









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Fig. 4 Total ion chromatograms of bacterial headspace samples. For
pre-concentration, VOCs of 2 L headspace volume have been adsorbed
to Tenax GR. Total ion chromatograms are shown from 7 to 28 min.
Identity of VOCs is summarized in Table 2. Cyclohexanol Rt0
12.17 min, styrene Rt012.35 min, cyclohexanone Rt012.45 min,
benzaldehyde Rt014.14 min, 2-ethyl-1-hexanol Rt015.61 min and
acetophenone Rt016.68 min have been detected as main volatile
compounds over Columbia sheep blood agar. Benzothiazole—a con-
taminant of the operation gas—has been detected in every headspace
sample at Rt020.37 min
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Determination of bacterial volatiles by GC/MS
Results of thermal desorption GC/MS analysis confirmed
the fact that bacteria can be discriminated by their VOC
patterns (Table 3, Fig. 4). As well as for MCC-IMS analysis
VOCs determined by GC/MS are either termed by their
names and/or by numbers from 1* to 47* according to
Table 3. Contrary to MCC-IMS studies, where 10 mL of
headspace samples has been analyzed, 2 L of headspace
samples has been analyzed by GC/MS. In total 47 different
VOCs were detected over investigated strains but not over
Columbia sheep blood agar alone. Consequently, an endog-
enous origin of these compounds can be assumed. In con-
trast, VOCs, with increased amounts compared to Columbia
sheep blood agar background, were not taken in to account
like benzaldehyde, which massively increases in its concen-
tration over E. coli (Fig. 3). The elucidation of the origin of
those compounds is difficult and has been discussed lately
(Schulz and Dickschat 2007). Volatile compounds, which
were consumed by microorganisms, were also not investi-
gated further.
Discussion
Currently, the identification of human pathogenic bacteria
takes, with 2 to 4 days after infection suspicion, too much
time using routine diagnostics. An innovative tool to possibly
overcome bacterial identification problems is the MCC-IMS.
The results of this study demonstrate that it is indeed possible
to differentiate all 15 bacterial strains by their different VOC
patterns via the fast and powerful tool MCC-IMS (Table 1).
Analysis in positive or negative ion mode only would lead to
less discriminating power and cannot be recommended. Both
ionization modes used in this investigation are important for
pathogen differentiation.
The differentiability of pathogens per se could also be
confirmed by corresponding GC/MS analyses of several
strains (Table 3).
Actually, the identification of bacterial species by MCC-
IMS is a phenotypic method. Using this approach, different
VOC patterns have been detected for 15 investigated bacte-
rial strains. As we focused on bacterial discrimination by the
innovative tool MCC-IMS primarily as a proof of principle,
the time-consuming GC/MS analyses have not been per-
formed for all bacteria investigated. Identification of un-
known MCC-IMS signals was our secondary aim only and
has to be given more emphasise in the future. Due to
different properties of both analytical methods, not all com-
pounds detected by thermal desorption (TD)–GC/MS could
be verified by MCC-IMS and vice versa. Most important
properties of the analytical systems are highlighted in Ta-
ble 4. The MCC-IMS offers a powerful analysis of smaller
molecules in complex gas mixtures. The high separation
power of small molecules is based on a doubled separation,
primary the chromatographic by MCC and secondary by
differences in drift time in the IMS. However, only volatile
compounds which are ionisable can be accelerated in the
IMS drift region and thus are detectable. That is one reason
for the gap between compounds detected with GC/MS and
MCC-IMS. Further on, even if some of the signals detected
with MCC-IMS have been assigned to volatile compounds
by comparison to GC/MS measurements and reference
measurements, not all signals have been elucidated up to
now. Therefore, further investigations are necessary to as-
sign unknown MCC-IMS signals and to develop a microbi-
ological reference database for MCC-IMS data. Hence, it
perfectly complements and improves already existing meth-
ods like Gram staining and susceptibility tests. But even if
not all MCC-IMS signals could be assigned to volatile
compounds so far, the MCC-IMS is a promising tool to be
used for clinical samples in the near future.
Some of the MCC-IMS signals have been assigned to
corresponding GC/MS signals (Table 2). For these com-
pounds, even quantitative measurements after calibration
of the device to these compounds are possible. Thus, the
MCC-IMS demonstrates its capacity beyond plain pheno-
typic tools as the electronic noses (Pavlou et al. 2002).
Table 4 Comparison of methodical properties
Property MCC-IMS TD-GC/MS
Sample volume 10 mL 2 L
Sample preparation No pre-concentration needed Pre-concentration on, e.g., Tenax
Molecular weight of analytes Approx. 17–180 g/mol Approx. 85–200 g/mol
Duration of sampling 5 min 20 min
Duration of sample analysis 10 min 60 min
Data analysis (reference databases) Approx. 120 compounds More than 190,000 compounds NIST standard reference database
ISAS customized database
Temperature program during analysis Isothermally at 40 °C Gradient from 35 °C to 250 °C
Necessity of vacuum for separation Not needed Necessary
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A further aspect, also important for the current investiga-
tion, is the detection of compound dimers. As previously
described 63Ni as ionization source leads to the formation of
proton bound monomers and can also lead under certain
conditions (e.g., high concentrations) to the formation of
proton bound dimers using positive ion mode (Borsdorf
and Eiceman 2006). The formation of proton bound dimers
might be present for detected compounds in this investiga-
tion as well. Therefore, p_818_26 (15) could be the proton
bound dimer of p_749_26 (9) and p_774_4 (12) could be
the proton bound dimer of p_771_3 (8). This phenomenon
can be observed in this study for measurements in negative ion
mode too and has also been previously reported (Borsdorf and
Eiceman 2006). Accordingly, indole has been detected as
negatively charged monomer (25) in K. oxytoca and E. coli
but the negatively charged dimer (31) has been determined
over E. coli only. The occurrence of the indole dimer was
associated with high signal intensities for an indole monomer.
Further on the monomer p_563_24 (20) and the
corresponding dimer p_591_24 (23) were detected over C.
freundii. Likewise it seems to be the case for the signals
p_688_22 (29) and p_744_22 (30) from C. freundii although
their relations need to be investigated further. In addition the
compounds p_572_8 (21) and p_599_10 (24), widely distrib-
uted over the investigated strains, seem to be the negatively
charged monomer and dimer as well.
In this context, we made no attempts to distinguish be-
tween different isolates of one species, since the present
investigation was designed as a proof of principle. Further-
more, we did not quantify VOC amounts and bacterial
cultures, we did not determine detection limits and we did
not check different growth media although it is known that
medium and growth conditions strongly influence VOC
compositions (Wagner et al. 2003; Schulz and Dickschat
2007). We rather used a medium which is routinely used
in clinical laboratories (Columbia sheep blood agar). In
addition, we made no attempts to optimize the setup as par
example variation of sample gas flow. We used a sample gas
flow of 100 mL/min to rinse the headspace of the measure-
ment chamber and the sample loop to sample 10 mL after-
wards. A reduction of sample gas flow will lead to a higher
concentration of volatile compounds and therefore differ-
ences might occur in lower bacterial count.
Moreover, we focused in this investigation on com-
pounds which have apparently been formed by pathogens
and which are not present over Columbia blood agar alone.
The origin of benzaldehyde for example, which is massively
released by E. coli and is also present in moderate amounts
over the used medium alone, has to be studied in further
investigations. Benzaldehyde has been published as VOC of
several bacteria though (Schulz and Dickschat 2007).
The major advantage of the MCC-IMS system is the fea-
sibility of rapid measurements without pre-concentration or
preparation of samples and analysis of complex gas mixtures
regardless of the water vapour content in an online setup with
relatively low technical expenditure. Beside the discrimina-
tion of different pathogens by volatile metabolic profiles
grown on agar plates, the detection of respective VOCs in
patients’ breath suffering from infections or with infection
suspicion might be the most promising approach. But since
VOC patterns of bacteria depend on growth conditions and
growth phase (O’Hara and Mayhew 2009), pathogen deter-
mination by breath sampling could lead to different VOC
patterns. Also infection related endogenous compounds could
be detected in patient’s breath. Consequently, an earlier diag-
nosis of infections and identification of pathogens by MCC-
IMS leading to an early and appropriate therapy could be
achieved compared to current strategies.
In summary, the application of multi-capillary column–
ion mobility spectrometry with respect to a rather fast iden-
tification of human pathogenic bacteria could be realised by
determination of their specific volatile metabolomes. It is
possible to determine volatile organic compound pattern of
15 human pathogenic bacteria directly, which were grown
on Columbia blood agar plates. Besides MCC-IMS deter-
mination TD-GC/MS was used to confirm and evaluate the
MCC-IMS data obtained. In addition, GC/MS helps to
assign volatile compounds to so far unknown MCC-IMS
signals. All investigated strains showed different VOC pat-
terns by MCC-IMS using positive and negative ion mode
for every single strain. Thus, the discrimination of investi-
gated bacteria is possible by detection of their volatile
organic compounds in the chosen experimental setup with
the fast and cost-effective method MCC-IMS leading to a
possible reduction of microbial identification time from 2 to
4 days by traditional methods to only 24 h by using the
MCC-IMS.
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